Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | CYP2A6 | P11509 | 6/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.39 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.39 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.37 |
| ▸ | WDR5 | P61964 | 1/20 | 0.35 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA7 | P43166 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29583781 | 1.00 | MAPT (0.40) | MAPTCYP2A6ALDH1A1HSD17B10TDP1 | |
| SCHEMBL2824075 | 0.82 | HSD17B10 (0.44) | MAPTCYP2A6ALDH1A1HSD17B10TDP1 | |
| SCHEMBL29489771 | 0.82 | HSD17B10 (0.44) | MAPTCYP2A6ALDH1A1HSD17B10TDP1 | |
| SCHEMBL29489770 | 0.82 | HSD17B10 (0.44) | MAPTCYP2A6ALDH1A1HSD17B10TDP1 | |
| SCHEMBL2079041 | 0.80 | TSHR (0.39) | MAPTCYP2A6ALDH1A1HSD17B10TDP1 | |
| SCHEMBL29583333 | 0.80 | TSHR (0.39) | MAPTCYP2A6ALDH1A1HSD17B10TDP1 | |
| SCHEMBL1925137 | 0.80 | GAA (0.38) | MAPTCYP2A6ALDH1A1HSD17B10TDP1 | |
| SCHEMBL29584848 | 0.80 | GAA (0.38) | MAPTCYP2A6ALDH1A1HSD17B10TDP1 | |
| SCHEMBL301064 | 0.79 | CYP2A6 (0.40) | MAPTCYP2A6ALDH1A1HSD17B10TDP1 | |
| Hydrochloric Acid SCHEMBL7943427 | 0.77 | TSHR (0.37) | MAPTCYP2A6ALDH1A1HSD17B10TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2123357-B1 | CYANATION CATALYST AND METHOD FOR PRODUCING OPTICALLY ACTIVE CYANHYDRIN COMPOUND USING THE SAME | UNIV HOKKAIDO NAT UNIV CORP (JP) | 2013-04-17 | — | — | EP | disclosed |
| US-8163947-B2 | Cyanation catalyst and method for producing optically active cyanhydrin compound using the same | NATIONAL UNIVERSITY CORPORATION, HOKKAIDO UNIVERSITY (JP) | 2012-04-24 | — | — | US | disclosed |
| EP-1813621-B1 | RUTHENIUM COMPLEX AND PROCESS FOR PRODUCING TERT-ALKYL ALCOHOL THEREWITH | NAGOYA IND SCIENCE RES INST (JP) | 2011-06-08 | — | — | EP | disclosed |
| US-20100029977-A1 | CYANATION CATALYST AND METHOD FOR PRODUCING OPTICALLY ACTIVE CYANHYDRIN COMPOUND USING THE SAME | NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (JP) | 2010-02-04 | — | — | US | disclosed |
| US-7378560-B2 | Ruthenium complex and process for producing tert-alkyl alcohol therewith | KANTO KANGAKU KABUSHIKI KAISHA (JP) | 2008-05-27 | — | — | US | disclosed |
| US-20070265448-A1 | Ruthenium Complex and Process for Producing Tert-Alkyl Alcohol Therewith | KANTO KAGAKU KABUSHIKI KAISHA (JP) | 2007-11-15 | — | — | US | disclosed |
| US-20070225528-A1 | Process for Producing Optically Active Alcohol | NAGOYA INDUSTRIAL SCIENCE RESEARCH CENTER (JP) | 2007-09-27 | — | — | US | disclosed |
| EP-1813621-A1 | RUTHENIUM COMPLEX AND PROCESS FOR PRODUCING TERT-ALKYL ALCOHOL THEREWITH | Nagoya Industrial Science Research Institute (JP) | 2007-08-01 | — | — | EP | disclosed |
| EP-1741693-A1 | PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE ALCOHOLS | Nagoya Industrial Science Research Institute (JP) | 2007-01-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070225528-A1 | Process for Producing Optically Active Alcohol | ADH1C, ADH1A, ADH5 | MAPT 2709/4885CYP2A6 1034/4885ALDH1A1 277/4885 |
| US-20070265448-A1 | Ruthenium Complex and Process for Producing Tert-Alkyl Alcohol Therewith | TERT, ADH1C, ADH1A | MAPT 2712/4885CYP2A6 1259/4885ALDH1A1 366/4885 |
| US-20100029977-A1 | CYANATION CATALYST AND METHOD FOR PRODUCING OPTICALLY ACTIVE CYANHYDRIN COMPOUND USING THE SAME | TYR, IK, CYB5R3 | MAPT 4253/4885CYP2A6 1455/4885ALDH1A1 2995/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.